Celiac Disease during Interferon Treatment
- Maria Teresa Bardella, MD;
- Roberta Marino, MD; and
- Pier Luigi Meroni, MD
- IRCCS Ospedale Maggiore; Milan, Italy (Bardella) IRCCS Ospedale Maggiore; Milan, Italy (Marino) IRCCS Ospedale Maggiore; Milan, Italy (Meroni)
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
